Effectiveness of trivalent inactivated influenza vaccines in children during 2017–2018 season in Korea: Comparison of test-negative analysis by rapid and RT-PCR influenza tests
- Authors
- Sohn, Y.J.; Choi, J.H.; Choi, Y.Y.; Choe, Y.J.; Kim, K.; Kim, Y.K.; Ahn, B.; Song, S.H.; Han, M.S.; Park, J.Y.; Lee, J.K.; Choi, E.H.
- Issue Date
- Oct-2020
- Publisher
- Elsevier B.V.
- Keywords
- Children; Inactivated influenza vaccine; Seasonal influenza; Vaccine effectiveness
- Citation
- International Journal of Infectious Diseases, v.99, pp 199 - 203
- Pages
- 5
- Journal Title
- International Journal of Infectious Diseases
- Volume
- 99
- Start Page
- 199
- End Page
- 203
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/63234
- DOI
- 10.1016/j.ijid.2020.07.032
- ISSN
- 1201-9712
1878-3511
- Abstract
- Objectives: In Korea, the National Immunization Program provided trivalent inactivated influenza vaccines (IIV3) to all children aged 6–59 months during the 2017–2018 season. In this study, we aimed to evaluate the vaccine effectiveness (VE) of IIV3 in children during the 2017–2018 season. Methods: Children aged 6–59 months who were tested for influenza for their acute respiratory illness in four hospitals during the 2017–2018 influenza season were included. We estimated the VE of IIV3 by test-negative case-control design based on the rapid influenza diagnostic test (RIDT) or reverse transcription polymerase chain reaction (RT-PCR) test results. Results: A total of 4738 children were included in this study. The number of laboratory-confirmed influenza cases was 845 (17.8%), and there were 478 cases of influenza A and 362 cases of influenza B. The adjusted VE based on RT-PCR was 53.4% (95% CI, 25.3–70.5) against any influenza, 68.8% (95% CI, 38.7–84.1) against influenza A, and 29.7% (95% CI, −35.1 to 61.8) for influenza B. The adjusted VE based on RIDT was 14.8% (95% CI, −4.4 to 30.0) against any influenza, 24.2% (95% CI, 3.1–40.2) against influenza A, and −5.1% (95% CI, −42.6 to 21.4) against influenza B. Age-specific VE based on RT-PCR against any influenza was 44.1% (95% CI, −0.2 to 67.8) in children aged 6 months to 2 years and 59.3% (95% CI, 8.8–81.9) in children aged 3–<5 years. Conclusion: Our results suggest moderate protection (53.4%) of IIV3 against RT-PCR laboratory-confirmed influenza in children in the 2017–2018 influenza season. However, the RIDT hampered the validity to assess VE during influenza season. Caution is needed when interpreting an RIDT-based test negative design influenza VE study. © 2020 The Authors
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/63234)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.